JP2003503016A

JP2003503016A - ソーティングネキシン

ソーティングネキシン

Info

Publication number: JP2003503016A
Authority: JP; Japan
Prior art keywords: polynucleotide; snexn; polypeptide; sequence; seq
Prior art date: 1999-05-27
Legal status : Pending

Application number

JP2001500658A

Other languages

English (en)

Japanese (ja)

Inventor

ユエ、ヘンリー

タング、ワイ・トム

アジムザイ、ヤルダ

Original Assignee

インサイト・ゲノミックス・インコーポレイテッド

Priority date

1999-05-27

Filing date

2000-05-26

Publication date

2003-01-28

2000-05-26 Application filed by インサイト・ゲノミックス・インコーポレイテッド filed Critical インサイト・ゲノミックス・インコーポレイテッド

2003-01-28 Publication of JP2003503016A publication Critical patent/JP2003503016A/ja

Status Pending legal-status Critical Current

Links

108060007774 sorting nexin Proteins 0.000 title abstract description 305
102000005045 Sorting Nexin Human genes 0.000 title abstract description 304
108091033319 polynucleotide Proteins 0.000 claims abstract description 221
102000040430 polynucleotide Human genes 0.000 claims abstract description 221
239000002157 polynucleotide Substances 0.000 claims abstract description 221
238000000034 method Methods 0.000 claims abstract description 213
230000014509 gene expression Effects 0.000 claims abstract description 110
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 74
201000010099 disease Diseases 0.000 claims abstract description 50
239000005557 antagonist Substances 0.000 claims abstract description 18
239000000556 agonist Substances 0.000 claims abstract description 17
108090000765 processed proteins & peptides Proteins 0.000 claims description 139
239000012634 fragment Substances 0.000 claims description 134
102000004196 processed proteins & peptides Human genes 0.000 claims description 120
229920001184 polypeptide Polymers 0.000 claims description 113
125000003275 alpha amino acid group Chemical group 0.000 claims description 101
150000001875 compounds Chemical class 0.000 claims description 90
239000000523 sample Substances 0.000 claims description 73
239000002773 nucleotide Substances 0.000 claims description 68
125000003729 nucleotide group Chemical group 0.000 claims description 68
238000009396 hybridization Methods 0.000 claims description 63
230000000694 effects Effects 0.000 claims description 55
230000027455 binding Effects 0.000 claims description 49
238000012360 testing method Methods 0.000 claims description 42
238000011282 treatment Methods 0.000 claims description 39
230000000295 complement effect Effects 0.000 claims description 33
238000012216 screening Methods 0.000 claims description 28
239000008194 pharmaceutical composition Substances 0.000 claims description 23
230000002163 immunogen Effects 0.000 claims description 20
238000004519 manufacturing process Methods 0.000 claims description 20
230000008569 process Effects 0.000 claims description 18
230000008859 change Effects 0.000 claims description 15
208000024891 symptom Diseases 0.000 claims description 10
230000003247 decreasing effect Effects 0.000 claims description 9
239000000546 pharmaceutical excipient Substances 0.000 claims description 8
235000003869 genetically modified organism Nutrition 0.000 claims description 6
238000012258 culturing Methods 0.000 claims description 4
230000002018 overexpression Effects 0.000 claims description 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
230000001131 transforming effect Effects 0.000 claims 1
241000282414 Homo sapiens Species 0.000 abstract description 27
239000013604 expression vector Substances 0.000 abstract description 23
108090000623 proteins and genes Proteins 0.000 description 165
210000004027 cell Anatomy 0.000 description 158
102000004169 proteins and genes Human genes 0.000 description 91
235000018102 proteins Nutrition 0.000 description 86
150000007523 nucleic acids Chemical group 0.000 description 83
239000013598 vector Substances 0.000 description 61
108020004414 DNA Proteins 0.000 description 57
239000002299 complementary DNA Substances 0.000 description 50
108091028043 Nucleic acid sequence Proteins 0.000 description 49
108091032973 (ribonucleotides)n+m Proteins 0.000 description 41
239000013615 primer Substances 0.000 description 40
210000001519 tissue Anatomy 0.000 description 40
108091034117 Oligonucleotide Proteins 0.000 description 39
102000039446 nucleic acids Human genes 0.000 description 35
108020004707 nucleic acids Proteins 0.000 description 35
239000000203 mixture Substances 0.000 description 34
235000001014 amino acid Nutrition 0.000 description 31
238000003752 polymerase chain reaction Methods 0.000 description 31
150000001413 amino acids Chemical class 0.000 description 27
239000013612 plasmid Substances 0.000 description 27
229940024606 amino acid Drugs 0.000 description 26
238000004458 analytical method Methods 0.000 description 25
238000005516 engineering process Methods 0.000 description 23
238000003556 assay Methods 0.000 description 22
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 21
208000035475 disorder Diseases 0.000 description 21
238000002493 microarray Methods 0.000 description 21
238000000746 purification Methods 0.000 description 20
238000012163 sequencing technique Methods 0.000 description 20
230000001105 regulatory effect Effects 0.000 description 19
239000000758 substrate Substances 0.000 description 18
206010028980 Neoplasm Diseases 0.000 description 17
239000003814 drug Substances 0.000 description 17
230000002068 genetic effect Effects 0.000 description 16
238000006467 substitution reaction Methods 0.000 description 16
108091026890 Coding region Proteins 0.000 description 15
238000004422 calculation algorithm Methods 0.000 description 15
238000013518 transcription Methods 0.000 description 15
230000035897 transcription Effects 0.000 description 15
241001465754 Metazoa Species 0.000 description 14
230000003321 amplification Effects 0.000 description 14
230000000692 anti-sense effect Effects 0.000 description 14
201000011510 cancer Diseases 0.000 description 14
239000003153 chemical reaction reagent Substances 0.000 description 14
210000000349 chromosome Anatomy 0.000 description 14
238000003199 nucleic acid amplification method Methods 0.000 description 14
102000005962 receptors Human genes 0.000 description 14
108020003175 receptors Proteins 0.000 description 14
238000013519 translation Methods 0.000 description 14
239000000243 solution Substances 0.000 description 13
239000000126 substance Substances 0.000 description 13
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
230000006870 function Effects 0.000 description 12
238000000338 in vitro Methods 0.000 description 12
239000012528 membrane Substances 0.000 description 12
208000011580 syndromic disease Diseases 0.000 description 12
238000012546 transfer Methods 0.000 description 12
102000004190 Enzymes Human genes 0.000 description 11
108010038807 Oligopeptides Proteins 0.000 description 11
102000015636 Oligopeptides Human genes 0.000 description 11
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 11
238000006243 chemical reaction Methods 0.000 description 11
229940088598 enzyme Drugs 0.000 description 11
108020001507 fusion proteins Proteins 0.000 description 11
102000037865 fusion proteins Human genes 0.000 description 11
239000005090 green fluorescent protein Substances 0.000 description 11
230000003993 interaction Effects 0.000 description 11
230000032258 transport Effects 0.000 description 11
108090000790 Enzymes Proteins 0.000 description 10
208000026350 Inborn Genetic disease Diseases 0.000 description 10
241000124008 Mammalia Species 0.000 description 10
240000004808 Saccharomyces cerevisiae Species 0.000 description 10
125000000539 amino acid group Chemical group 0.000 description 10
230000001580 bacterial effect Effects 0.000 description 10
210000000170 cell membrane Anatomy 0.000 description 10
238000001415 gene therapy Methods 0.000 description 10
208000016361 genetic disease Diseases 0.000 description 10
239000003446 ligand Substances 0.000 description 10
230000004048 modification Effects 0.000 description 10
238000012986 modification Methods 0.000 description 10
230000035772 mutation Effects 0.000 description 10
241000894007 species Species 0.000 description 10
-1 Gin Chemical compound 0.000 description 9
206010061218 Inflammation Diseases 0.000 description 9
241000699666 Mus <mouse, genus> Species 0.000 description 9
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 9
230000000875 corresponding effect Effects 0.000 description 9
230000007812 deficiency Effects 0.000 description 9
230000004054 inflammatory process Effects 0.000 description 9
108020004999 messenger RNA Proteins 0.000 description 9
230000002438 mitochondrial effect Effects 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
210000002460 smooth muscle Anatomy 0.000 description 9
239000007787 solid Substances 0.000 description 9
238000001890 transfection Methods 0.000 description 9
241000701161 unidentified adenovirus Species 0.000 description 9
230000003612 virological effect Effects 0.000 description 9
241000710929 Alphavirus Species 0.000 description 8
102000008102 Ankyrins Human genes 0.000 description 8
108010049777 Ankyrins Proteins 0.000 description 8
108010043121 Green Fluorescent Proteins Proteins 0.000 description 8
102000004144 Green Fluorescent Proteins Human genes 0.000 description 8
208000003250 Mixed connective tissue disease Diseases 0.000 description 8
241000283973 Oryctolagus cuniculus Species 0.000 description 8
108091093037 Peptide nucleic acid Proteins 0.000 description 8
239000004698 Polyethylene Substances 0.000 description 8
241000700584 Simplexvirus Species 0.000 description 8
241000700605 Viruses Species 0.000 description 8
238000010367 cloning Methods 0.000 description 8
238000010276 construction Methods 0.000 description 8
238000001514 detection method Methods 0.000 description 8
238000003745 diagnosis Methods 0.000 description 8
229940079593 drug Drugs 0.000 description 8
230000001939 inductive effect Effects 0.000 description 8
239000003112 inhibitor Substances 0.000 description 8
239000003550 marker Substances 0.000 description 8
230000001225 therapeutic effect Effects 0.000 description 8
206010016654 Fibrosis Diseases 0.000 description 7
208000018522 Gastrointestinal disease Diseases 0.000 description 7
102000005720 Glutathione transferase Human genes 0.000 description 7
108010070675 Glutathione transferase Proteins 0.000 description 7
208000021642 Muscular disease Diseases 0.000 description 7
208000012902 Nervous system disease Diseases 0.000 description 7
208000025966 Neurological disease Diseases 0.000 description 7
108010077850 Nuclear Localization Signals Proteins 0.000 description 7
108010076504 Protein Sorting Signals Proteins 0.000 description 7
102100030992 Sorting nexin-1 Human genes 0.000 description 7
238000012217 deletion Methods 0.000 description 7
230000037430 deletion Effects 0.000 description 7
239000003623 enhancer Substances 0.000 description 7
239000011521 glass Substances 0.000 description 7
210000000688 human artificial chromosome Anatomy 0.000 description 7
208000026278 immune system disease Diseases 0.000 description 7
238000001727 in vivo Methods 0.000 description 7
238000002372 labelling Methods 0.000 description 7
230000001404 mediated effect Effects 0.000 description 7
238000011160 research Methods 0.000 description 7
235000000346 sugar Nutrition 0.000 description 7
229940124597 therapeutic agent Drugs 0.000 description 7
230000009466 transformation Effects 0.000 description 7
108090000994 Catalytic RNA Proteins 0.000 description 6
102000053642 Catalytic RNA Human genes 0.000 description 6
241000196324 Embryophyta Species 0.000 description 6
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
102000010995 Pleckstrin homology domains Human genes 0.000 description 6
108050001185 Pleckstrin homology domains Proteins 0.000 description 6
102000000395 SH3 domains Human genes 0.000 description 6
108050008861 SH3 domains Proteins 0.000 description 6
230000005856 abnormality Effects 0.000 description 6
239000002671 adjuvant Substances 0.000 description 6
230000000890 antigenic effect Effects 0.000 description 6
230000004071 biological effect Effects 0.000 description 6
210000001124 body fluid Anatomy 0.000 description 6
239000010839 body fluid Substances 0.000 description 6
239000000872 buffer Substances 0.000 description 6
230000002759 chromosomal effect Effects 0.000 description 6
230000007882 cirrhosis Effects 0.000 description 6
208000019425 cirrhosis of liver Diseases 0.000 description 6
238000011161 development Methods 0.000 description 6
230000018109 developmental process Effects 0.000 description 6
238000009472 formulation Methods 0.000 description 6
208000006454 hepatitis Diseases 0.000 description 6
231100000283 hepatitis Toxicity 0.000 description 6
230000028993 immune response Effects 0.000 description 6
230000001965 increasing effect Effects 0.000 description 6
230000003834 intracellular effect Effects 0.000 description 6
238000013507 mapping Methods 0.000 description 6
230000007246 mechanism Effects 0.000 description 6
230000002062 proliferating effect Effects 0.000 description 6
230000001177 retroviral effect Effects 0.000 description 6
108091092562 ribozyme Proteins 0.000 description 6
238000003786 synthesis reaction Methods 0.000 description 6
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
238000005406 washing Methods 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
108020004705 Codon Proteins 0.000 description 5
102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 5
101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 5
101000637249 Homo sapiens Nexilin Proteins 0.000 description 5
208000029578 Muscle disease Diseases 0.000 description 5
102100031801 Nexilin Human genes 0.000 description 5
108091034057 RNA (poly(A)) Proteins 0.000 description 5
101710103909 Sorting nexin-1 Proteins 0.000 description 5
238000010171 animal model Methods 0.000 description 5
238000000137 annealing Methods 0.000 description 5
239000000427 antigen Substances 0.000 description 5
108091007433 antigens Proteins 0.000 description 5
102000036639 antigens Human genes 0.000 description 5
230000004663 cell proliferation Effects 0.000 description 5
230000007547 defect Effects 0.000 description 5
239000012153 distilled water Substances 0.000 description 5
210000001035 gastrointestinal tract Anatomy 0.000 description 5
230000013595 glycosylation Effects 0.000 description 5
238000006206 glycosylation reaction Methods 0.000 description 5
230000002209 hydrophobic effect Effects 0.000 description 5
238000003018 immunoassay Methods 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
238000003780 insertion Methods 0.000 description 5
230000037431 insertion Effects 0.000 description 5
238000004806 packaging method and process Methods 0.000 description 5
230000002265 prevention Effects 0.000 description 5
238000012545 processing Methods 0.000 description 5
230000004044 response Effects 0.000 description 5
230000007017 scission Effects 0.000 description 5
150000003384 small molecules Chemical class 0.000 description 5
241000701447 unidentified baculovirus Species 0.000 description 5
241001430294 unidentified retrovirus Species 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 4
208000030507 AIDS Diseases 0.000 description 4
206010002198 Anaphylactic reaction Diseases 0.000 description 4
206010003210 Arteriosclerosis Diseases 0.000 description 4
201000001320 Atherosclerosis Diseases 0.000 description 4
206010006811 Bursitis Diseases 0.000 description 4
108020004635 Complementary DNA Proteins 0.000 description 4
208000011231 Crohn disease Diseases 0.000 description 4
238000002965 ELISA Methods 0.000 description 4
241000588724 Escherichia coli Species 0.000 description 4
208000032027 Essential Thrombocythemia Diseases 0.000 description 4
201000011240 Frontotemporal dementia Diseases 0.000 description 4
208000030836 Hashimoto thyroiditis Diseases 0.000 description 4
101710154606 Hemagglutinin Proteins 0.000 description 4
241000282412 Homo Species 0.000 description 4
101000837849 Homo sapiens Trans-Golgi network integral membrane protein 2 Proteins 0.000 description 4
208000023105 Huntington disease Diseases 0.000 description 4
206010025323 Lymphomas Diseases 0.000 description 4
101710093908 Outer capsid protein VP4 Proteins 0.000 description 4
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 4
206010033645 Pancreatitis Diseases 0.000 description 4
208000000733 Paroxysmal Hemoglobinuria Diseases 0.000 description 4
102100036050 Phosphatidylinositol N-acetylglucosaminyltransferase subunit A Human genes 0.000 description 4
ZYFVNVRFVHJEIU-UHFFFAOYSA-N PicoGreen Chemical compound CN(C)CCCN(CCCN(C)C)C1=CC(=CC2=[N+](C3=CC=CC=C3S2)C)C2=CC=CC=C2N1C1=CC=CC=C1 ZYFVNVRFVHJEIU-UHFFFAOYSA-N 0.000 description 4
101710176177 Protein A56 Proteins 0.000 description 4
201000004681 Psoriasis Diseases 0.000 description 4
241000714474 Rous sarcoma virus Species 0.000 description 4
108091081024 Start codon Proteins 0.000 description 4
108091008874 T cell receptors Proteins 0.000 description 4
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 4
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
201000011032 Werner Syndrome Diseases 0.000 description 4
208000017733 acquired polycythemia vera Diseases 0.000 description 4
239000004480 active ingredient Substances 0.000 description 4
238000007792 addition Methods 0.000 description 4
208000003455 anaphylaxis Diseases 0.000 description 4
238000013459 approach Methods 0.000 description 4
208000011775 arteriosclerosis disease Diseases 0.000 description 4
208000006673 asthma Diseases 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
210000000988 bone and bone Anatomy 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
230000006037 cell lysis Effects 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
201000001352 cholecystitis Diseases 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
201000001981 dermatomyositis Diseases 0.000 description 4
230000006806 disease prevention Effects 0.000 description 4
210000002472 endoplasmic reticulum Anatomy 0.000 description 4
206010015037 epilepsy Diseases 0.000 description 4
238000002474 experimental method Methods 0.000 description 4
238000000684 flow cytometry Methods 0.000 description 4
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
210000002216 heart Anatomy 0.000 description 4
239000000185 hemagglutinin Substances 0.000 description 4
238000002744 homologous recombination Methods 0.000 description 4
230000006801 homologous recombination Effects 0.000 description 4
208000014674 injury Diseases 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
208000032839 leukemia Diseases 0.000 description 4
239000002502 liposome Substances 0.000 description 4
210000004072 lung Anatomy 0.000 description 4
239000006166 lysate Substances 0.000 description 4
210000003712 lysosome Anatomy 0.000 description 4
230000001868 lysosomic effect Effects 0.000 description 4
229920002521 macromolecule Polymers 0.000 description 4
238000002156 mixing Methods 0.000 description 4
238000012544 monitoring process Methods 0.000 description 4
201000006417 multiple sclerosis Diseases 0.000 description 4
201000006938 muscular dystrophy Diseases 0.000 description 4
206010028417 myasthenia gravis Diseases 0.000 description 4
210000005036 nerve Anatomy 0.000 description 4
201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 description 4
210000002824 peroxisome Anatomy 0.000 description 4
230000026731 phosphorylation Effects 0.000 description 4
238000006366 phosphorylation reaction Methods 0.000 description 4
208000037244 polycythemia vera Diseases 0.000 description 4
229920000642 polymer Polymers 0.000 description 4
102000054765 polymorphisms of proteins Human genes 0.000 description 4
208000005987 polymyositis Diseases 0.000 description 4
230000000750 progressive effect Effects 0.000 description 4
238000003127 radioimmunoassay Methods 0.000 description 4
230000006798 recombination Effects 0.000 description 4
238000005215 recombination Methods 0.000 description 4
230000010076 replication Effects 0.000 description 4
239000011347 resin Substances 0.000 description 4
229920005989 resin Polymers 0.000 description 4
108091008146 restriction endonucleases Proteins 0.000 description 4
208000012672 seasonal affective disease Diseases 0.000 description 4
230000009870 specific binding Effects 0.000 description 4
230000008733 trauma Effects 0.000 description 4
241001529453 unidentified herpesvirus Species 0.000 description 4
210000004291 uterus Anatomy 0.000 description 4
239000013603 viral vector Substances 0.000 description 4
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
208000024827 Alzheimer disease Diseases 0.000 description 3
241000972773 Aulopiformes Species 0.000 description 3
108091035707 Consensus sequence Proteins 0.000 description 3
241000701022 Cytomegalovirus Species 0.000 description 3
238000001712 DNA sequencing Methods 0.000 description 3
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 3
102000012737 Electron-Transferring Flavoproteins Human genes 0.000 description 3
108010079426 Electron-Transferring Flavoproteins Proteins 0.000 description 3
108010042407 Endonucleases Proteins 0.000 description 3
241001635598 Enicostema Species 0.000 description 3
241000238631 Hexapoda Species 0.000 description 3
241000725303 Human immunodeficiency virus Species 0.000 description 3
206010020751 Hypersensitivity Diseases 0.000 description 3
101000829171 Hypocrea virens (strain Gv29-8 / FGSC 10586) Effector TSP1 Proteins 0.000 description 3
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 3
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
102100034349 Integrase Human genes 0.000 description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
239000004472 Lysine Substances 0.000 description 3
101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 3
102000004722 NADPH Oxidases Human genes 0.000 description 3
108010002998 NADPH Oxidases Proteins 0.000 description 3
102100028418 Nuclear transport factor 2 Human genes 0.000 description 3
101710159639 Nuclear transport factor 2 Proteins 0.000 description 3
206010035226 Plasma cell myeloma Diseases 0.000 description 3
208000024777 Prion disease Diseases 0.000 description 3
241000700159 Rattus Species 0.000 description 3
108020004511 Recombinant DNA Proteins 0.000 description 3
102000014400 SH2 domains Human genes 0.000 description 3
108050003452 SH2 domains Proteins 0.000 description 3
241000710961 Semliki Forest virus Species 0.000 description 3
108091081021 Sense strand Proteins 0.000 description 3
229920002684 Sepharose Polymers 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
208000006011 Stroke Diseases 0.000 description 3
108010006785 Taq Polymerase Proteins 0.000 description 3
208000002903 Thalassemia Diseases 0.000 description 3
102100036407 Thioredoxin Human genes 0.000 description 3
108020004440 Thymidine kinase Proteins 0.000 description 3
241000723873 Tobacco mosaic virus Species 0.000 description 3
102100028621 Trans-Golgi network integral membrane protein 2 Human genes 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
208000009621 actinic keratosis Diseases 0.000 description 3
208000012130 acyl-CoA dehydrogenase deficiency Diseases 0.000 description 3
102000035181 adaptor proteins Human genes 0.000 description 3
108091005764 adaptor proteins Proteins 0.000 description 3
208000026935 allergic disease Diseases 0.000 description 3
230000007815 allergy Effects 0.000 description 3
239000011324 bead Substances 0.000 description 3
238000001574 biopsy Methods 0.000 description 3
210000002459 blastocyst Anatomy 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000001185 bone marrow Anatomy 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
210000003169 central nervous system Anatomy 0.000 description 3
230000002490 cerebral effect Effects 0.000 description 3
239000003184 complementary RNA Substances 0.000 description 3
238000004590 computer program Methods 0.000 description 3
206010012601 diabetes mellitus Diseases 0.000 description 3
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
208000037765 diseases and disorders Diseases 0.000 description 3
238000007877 drug screening Methods 0.000 description 3
230000002526 effect on cardiovascular system Effects 0.000 description 3
238000004520 electroporation Methods 0.000 description 3
230000002124 endocrine Effects 0.000 description 3
230000002255 enzymatic effect Effects 0.000 description 3
239000007850 fluorescent dye Substances 0.000 description 3
239000000499 gel Substances 0.000 description 3
238000010353 genetic engineering Methods 0.000 description 3
230000012010 growth Effects 0.000 description 3
ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
229940027941 immunoglobulin g Drugs 0.000 description 3
230000004068 intracellular signaling Effects 0.000 description 3
230000005291 magnetic effect Effects 0.000 description 3
210000004962 mammalian cell Anatomy 0.000 description 3
239000000463 material Substances 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
238000005259 measurement Methods 0.000 description 3
206010028537 myelofibrosis Diseases 0.000 description 3
201000000050 myeloid neoplasm Diseases 0.000 description 3
230000003472 neutralizing effect Effects 0.000 description 3
210000004940 nucleus Anatomy 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
210000003463 organelle Anatomy 0.000 description 3
239000002245 particle Substances 0.000 description 3
229940124531 pharmaceutical excipient Drugs 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
239000002987 primer (paints) Substances 0.000 description 3
230000000644 propagated effect Effects 0.000 description 3
230000002685 pulmonary effect Effects 0.000 description 3
238000011002 quantification Methods 0.000 description 3
230000005855 radiation Effects 0.000 description 3
102000005912 ran GTP Binding Protein Human genes 0.000 description 3
108010005597 ran GTP Binding Protein Proteins 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
235000019515 salmon Nutrition 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
208000002491 severe combined immunodeficiency Diseases 0.000 description 3
230000035939 shock Effects 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
108060008226 thioredoxin Proteins 0.000 description 3
229940113082 thymine Drugs 0.000 description 3
230000002792 vascular Effects 0.000 description 3
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
102100024643 ATP-binding cassette sub-family D member 1 Human genes 0.000 description 2
102000055025 Adenosine deaminases Human genes 0.000 description 2
206010001367 Adrenal insufficiency Diseases 0.000 description 2
201000011452 Adrenoleukodystrophy Diseases 0.000 description 2
206010001540 Akathisia Diseases 0.000 description 2
108700028369 Alleles Proteins 0.000 description 2
208000007887 Alphavirus Infections Diseases 0.000 description 2
208000024985 Alport syndrome Diseases 0.000 description 2
208000000044 Amnesia Diseases 0.000 description 2
208000031091 Amnestic disease Diseases 0.000 description 2
206010002556 Ankylosing Spondylitis Diseases 0.000 description 2
108020000948 Antisense Oligonucleotides Proteins 0.000 description 2
208000019901 Anxiety disease Diseases 0.000 description 2
208000004300 Atrophic Gastritis Diseases 0.000 description 2
208000012219 Autonomic Nervous System disease Diseases 0.000 description 2
208000023328 Basedow disease Diseases 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
208000004020 Brain Abscess Diseases 0.000 description 2
208000003174 Brain Neoplasms Diseases 0.000 description 2
208000014644 Brain disease Diseases 0.000 description 2
102000000584 Calmodulin Human genes 0.000 description 2
108010041952 Calmodulin Proteins 0.000 description 2
241000282472 Canis lupus familiaris Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
108090000565 Capsid Proteins Proteins 0.000 description 2
208000031229 Cardiomyopathies Diseases 0.000 description 2
102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 2
108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 2
206010058892 Carnitine deficiency Diseases 0.000 description 2
206010050215 Carnitine palmitoyltransferase deficiency Diseases 0.000 description 2
102000005572 Cathepsin A Human genes 0.000 description 2
108010059081 Cathepsin A Proteins 0.000 description 2
206010053684 Cerebrohepatorenal syndrome Diseases 0.000 description 2
102100023321 Ceruloplasmin Human genes 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108700010070 Codon Usage Proteins 0.000 description 2
ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
206010009900 Colitis ulcerative Diseases 0.000 description 2
206010009944 Colon cancer Diseases 0.000 description 2
108020004394 Complementary RNA Proteins 0.000 description 2
208000019736 Cranial nerve disease Diseases 0.000 description 2
208000014311 Cushing syndrome Diseases 0.000 description 2
201000003883 Cystic fibrosis Diseases 0.000 description 2
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
102000053602 DNA Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
206010012289 Dementia Diseases 0.000 description 2
208000016192 Demyelinating disease Diseases 0.000 description 2
206010012438 Dermatitis atopic Diseases 0.000 description 2
206010012442 Dermatitis contact Diseases 0.000 description 2
208000012239 Developmental disease Diseases 0.000 description 2
208000032131 Diabetic Neuropathies Diseases 0.000 description 2
201000010374 Down Syndrome Diseases 0.000 description 2
208000014094 Dystonic disease Diseases 0.000 description 2
206010014561 Emphysema Diseases 0.000 description 2
208000032274 Encephalopathy Diseases 0.000 description 2
102000004533 Endonucleases Human genes 0.000 description 2
241000701867 Enterobacteria phage T7 Species 0.000 description 2
206010014950 Eosinophilia Diseases 0.000 description 2
206010015226 Erythema nodosum Diseases 0.000 description 2
208000000461 Esophageal Neoplasms Diseases 0.000 description 2
206010061846 Extradural abscess Diseases 0.000 description 2
KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
208000003098 Ganglion Cysts Diseases 0.000 description 2
208000007882 Gastritis Diseases 0.000 description 2
208000036495 Gastritis atrophic Diseases 0.000 description 2
208000015872 Gaucher disease Diseases 0.000 description 2
208000007223 Gerstmann syndrome Diseases 0.000 description 2
208000003736 Gerstmann-Straussler-Scheinker Disease Diseases 0.000 description 2
206010072075 Gerstmann-Straussler-Scheinker syndrome Diseases 0.000 description 2
206010018364 Glomerulonephritis Diseases 0.000 description 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
108010024636 Glutathione Proteins 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
208000024869 Goodpasture syndrome Diseases 0.000 description 2
208000015023 Graves' disease Diseases 0.000 description 2
208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 2
101000702653 Homo sapiens Sorting nexin-1 Proteins 0.000 description 2
101000868440 Homo sapiens Sorting nexin-8 Proteins 0.000 description 2
102000004157 Hydrolases Human genes 0.000 description 2
108090000604 Hydrolases Proteins 0.000 description 2
206010020772 Hypertension Diseases 0.000 description 2
208000013016 Hypoglycemia Diseases 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
208000022559 Inflammatory bowel disease Diseases 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
206010025327 Lymphopenia Diseases 0.000 description 2
102000004083 Lymphotoxin-alpha Human genes 0.000 description 2
108090000542 Lymphotoxin-alpha Proteins 0.000 description 2
208000001826 Marfan syndrome Diseases 0.000 description 2
108010049137 Member 1 Subfamily D ATP Binding Cassette Transporter Proteins 0.000 description 2
206010027202 Meningitis bacterial Diseases 0.000 description 2
206010027260 Meningitis viral Diseases 0.000 description 2
208000036626 Mental retardation Diseases 0.000 description 2
208000026072 Motor neurone disease Diseases 0.000 description 2
208000003926 Myelitis Diseases 0.000 description 2
201000009623 Myopathy Diseases 0.000 description 2
206010028648 Myopathy toxic Diseases 0.000 description 2
206010068871 Myotonic dystrophy Diseases 0.000 description 2
208000023137 Myotoxicity Diseases 0.000 description 2
208000009905 Neurofibromatoses Diseases 0.000 description 2
206010030155 Oesophageal carcinoma Diseases 0.000 description 2
206010030216 Oesophagitis Diseases 0.000 description 2
108700026244 Open Reading Frames Proteins 0.000 description 2
208000001132 Osteoporosis Diseases 0.000 description 2
102000004316 Oxidoreductases Human genes 0.000 description 2
108090000854 Oxidoreductases Proteins 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
206010061902 Pancreatic neoplasm Diseases 0.000 description 2
208000018737 Parkinson disease Diseases 0.000 description 2
108010002747 Pfu DNA polymerase Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
208000000609 Pick Disease of the Brain Diseases 0.000 description 2
101710182846 Polyhedrin Proteins 0.000 description 2
206010036376 Postherpetic Neuralgia Diseases 0.000 description 2
241000288906 Primates Species 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
208000008425 Protein deficiency Diseases 0.000 description 2
208000001431 Psychomotor Agitation Diseases 0.000 description 2
208000028017 Psychotic disease Diseases 0.000 description 2
206010037714 Quadriplegia Diseases 0.000 description 2
108020004518 RNA Probes Proteins 0.000 description 2
239000003391 RNA probe Substances 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
206010037779 Radiculopathy Diseases 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
208000033464 Reiter syndrome Diseases 0.000 description 2
208000007014 Retinitis pigmentosa Diseases 0.000 description 2
201000000582 Retinoblastoma Diseases 0.000 description 2
108091028664 Ribonucleotide Proteins 0.000 description 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
108091006300 SLC2A4 Proteins 0.000 description 2
206010039710 Scleroderma Diseases 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
241000710960 Sindbis virus Species 0.000 description 2
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
102100032848 Sorting nexin-8 Human genes 0.000 description 2
208000009415 Spinocerebellar Ataxias Diseases 0.000 description 2
208000010112 Spinocerebellar Degenerations Diseases 0.000 description 2
208000005718 Stomach Neoplasms Diseases 0.000 description 2
201000000002 Subdural Empyema Diseases 0.000 description 2
108091027544 Subgenomic mRNA Proteins 0.000 description 2
208000005400 Synovial Cyst Diseases 0.000 description 2
201000009594 Systemic Scleroderma Diseases 0.000 description 2
206010042953 Systemic sclerosis Diseases 0.000 description 2
108091036066 Three prime untranslated region Proteins 0.000 description 2
102000006601 Thymidine Kinase Human genes 0.000 description 2
208000000323 Tourette Syndrome Diseases 0.000 description 2
108091023040 Transcription factor Proteins 0.000 description 2
102000040945 Transcription factor Human genes 0.000 description 2
108700036262 Trifunctional Protein Deficiency With Myopathy And Neuropathy Proteins 0.000 description 2
208000026911 Tuberous sclerosis complex Diseases 0.000 description 2
201000006704 Ulcerative Colitis Diseases 0.000 description 2
108091023045 Untranslated Region Proteins 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
241000700618 Vaccinia virus Species 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
208000027276 Von Willebrand disease Diseases 0.000 description 2
208000008383 Wilms tumor Diseases 0.000 description 2
201000004525 Zellweger Syndrome Diseases 0.000 description 2
208000036813 Zellweger spectrum disease Diseases 0.000 description 2
230000021736 acetylation Effects 0.000 description 2
238000006640 acetylation reaction Methods 0.000 description 2
230000009471 action Effects 0.000 description 2
208000009956 adenocarcinoma Diseases 0.000 description 2
210000004100 adrenal gland Anatomy 0.000 description 2
208000017515 adrenocortical insufficiency Diseases 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
230000006986 amnesia Effects 0.000 description 2
206010002022 amyloidosis Diseases 0.000 description 2
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
230000036783 anaphylactic response Effects 0.000 description 2
208000007502 anemia Diseases 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000000074 antisense oligonucleotide Substances 0.000 description 2
238000012230 antisense oligonucleotides Methods 0.000 description 2
230000036506 anxiety Effects 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
238000003491 array Methods 0.000 description 2
206010003119 arrhythmia Diseases 0.000 description 2
230000006793 arrhythmia Effects 0.000 description 2
210000004436 artificial bacterial chromosome Anatomy 0.000 description 2
201000008937 atopic dermatitis Diseases 0.000 description 2
201000000448 autoimmune hemolytic anemia Diseases 0.000 description 2
201000009904 bacterial meningitis Diseases 0.000 description 2
208000018300 basal ganglia disease Diseases 0.000 description 2
230000001588 bifunctional effect Effects 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
230000008827 biological function Effects 0.000 description 2
230000008236 biological pathway Effects 0.000 description 2
239000012472 biological sample Substances 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
210000000625 blastula Anatomy 0.000 description 2
239000002981 blocking agent Substances 0.000 description 2
210000004204 blood vessel Anatomy 0.000 description 2
210000000481 breast Anatomy 0.000 description 2
238000009395 breeding Methods 0.000 description 2
230000001488 breeding effect Effects 0.000 description 2
206010006451 bronchitis Diseases 0.000 description 2
238000010804 cDNA synthesis Methods 0.000 description 2
238000005251 capillar electrophoresis Methods 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
206010007776 catatonia Diseases 0.000 description 2
239000013592 cell lysate Substances 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
208000015114 central nervous system disease Diseases 0.000 description 2
206010008129 cerebral palsy Diseases 0.000 description 2
208000026106 cerebrovascular disease Diseases 0.000 description 2
210000003679 cervix uteri Anatomy 0.000 description 2
239000013522 chelant Substances 0.000 description 2
238000007385 chemical modification Methods 0.000 description 2
239000005081 chemiluminescent agent Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
238000003200 chromosome mapping Methods 0.000 description 2
208000016644 chronic atrophic gastritis Diseases 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
235000017471 coenzyme Q10 Nutrition 0.000 description 2
206010009887 colitis Diseases 0.000 description 2
208000029742 colonic neoplasm Diseases 0.000 description 2
238000012875 competitive assay Methods 0.000 description 2
208000010247 contact dermatitis Diseases 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
230000001086 cytosolic effect Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
239000003599 detergent Substances 0.000 description 2
230000029087 digestion Effects 0.000 description 2
239000000539 dimer Substances 0.000 description 2
VZFRNCSOCOPNDB-UHFFFAOYSA-N domoic acid Natural products OC(=O)C(C)C=CC=C(C)C1CNC(C(O)=O)C1CC(O)=O VZFRNCSOCOPNDB-UHFFFAOYSA-N 0.000 description 2
239000000975 dye Substances 0.000 description 2
208000010118 dystonia Diseases 0.000 description 2
238000000295 emission spectrum Methods 0.000 description 2
210000001163 endosome Anatomy 0.000 description 2
201000000165 epidural abscess Diseases 0.000 description 2
201000004101 esophageal cancer Diseases 0.000 description 2
208000006881 esophagitis Diseases 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
238000000605 extraction Methods 0.000 description 2
208000001031 fetal erythroblastosis Diseases 0.000 description 2
239000000835 fiber Substances 0.000 description 2
210000000232 gallbladder Anatomy 0.000 description 2
239000007789 gas Substances 0.000 description 2
206010017758 gastric cancer Diseases 0.000 description 2
230000002496 gastric effect Effects 0.000 description 2
238000012239 gene modification Methods 0.000 description 2
102000054767 gene variant Human genes 0.000 description 2
230000009395 genetic defect Effects 0.000 description 2
230000005017 genetic modification Effects 0.000 description 2
235000013617 genetically modified food Nutrition 0.000 description 2
229960003180 glutathione Drugs 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
238000001631 haemodialysis Methods 0.000 description 2
201000005787 hematologic cancer Diseases 0.000 description 2
208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
230000000322 hemodialysis Effects 0.000 description 2
206010073071 hepatocellular carcinoma Diseases 0.000 description 2
210000003494 hepatocyte Anatomy 0.000 description 2
201000003636 hereditary ataxia Diseases 0.000 description 2
208000003215 hereditary nephritis Diseases 0.000 description 2
210000003917 human chromosome Anatomy 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
230000002218 hypoglycaemic effect Effects 0.000 description 2
230000036737 immune function Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
238000011534 incubation Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
230000002452 interceptive effect Effects 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
238000007917 intracranial administration Methods 0.000 description 2
208000002551 irritable bowel syndrome Diseases 0.000 description 2
230000000302 ischemic effect Effects 0.000 description 2
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
206010023497 kuru Diseases 0.000 description 2
208000006443 lactic acidosis Diseases 0.000 description 2
231100000518 lethal Toxicity 0.000 description 2
230000001665 lethal effect Effects 0.000 description 2
230000029226 lipidation Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
210000004185 liver Anatomy 0.000 description 2
231100001023 lymphopenia Toxicity 0.000 description 2
239000006249 magnetic particle Substances 0.000 description 2
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
238000004949 mass spectrometry Methods 0.000 description 2
239000002609 medium Substances 0.000 description 2
201000001441 melanoma Diseases 0.000 description 2
208000030159 metabolic disease Diseases 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
VKHAHZOOUSRJNA-GCNJZUOMSA-N mifepristone Chemical compound C1([C@@H]2C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]3CC[C@@]([C@]3(C2)C)(O)C#CC)=CC=C(N(C)C)C=C1 VKHAHZOOUSRJNA-GCNJZUOMSA-N 0.000 description 2
208000014305 mitochondrial trifunctional protein deficiency Diseases 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
238000000329 molecular dynamics simulation Methods 0.000 description 2
239000003068 molecular probe Substances 0.000 description 2
230000036651 mood Effects 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
230000002107 myocardial effect Effects 0.000 description 2
208000010125 myocardial infarction Diseases 0.000 description 2
201000008026 nephroblastoma Diseases 0.000 description 2
201000004931 neurofibromatosis Diseases 0.000 description 2
210000002569 neuron Anatomy 0.000 description 2
230000000508 neurotrophic effect Effects 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
230000009871 nonspecific binding Effects 0.000 description 2
210000004492 nuclear pore Anatomy 0.000 description 2
206010030875 ophthalmoplegia Diseases 0.000 description 2
201000008482 osteoarthritis Diseases 0.000 description 2
210000001672 ovary Anatomy 0.000 description 2
210000000496 pancreas Anatomy 0.000 description 2
201000002528 pancreatic cancer Diseases 0.000 description 2
208000008443 pancreatic carcinoma Diseases 0.000 description 2
244000045947 parasite Species 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
230000001575 pathological effect Effects 0.000 description 2
230000007170 pathology Effects 0.000 description 2
210000003899 penis Anatomy 0.000 description 2
230000000737 periodic effect Effects 0.000 description 2
230000002974 pharmacogenomic effect Effects 0.000 description 2
208000028591 pheochromocytoma Diseases 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000001323 posttranslational effect Effects 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
239000002243 precursor Substances 0.000 description 2
201000009395 primary hyperaldosteronism Diseases 0.000 description 2
238000007639 printing Methods 0.000 description 2
210000002307 prostate Anatomy 0.000 description 2
230000004952 protein activity Effects 0.000 description 2
230000004850 protein–protein interaction Effects 0.000 description 2
230000006337 proteolytic cleavage Effects 0.000 description 2
208000020016 psychiatric disease Diseases 0.000 description 2
201000010108 pycnodysostosis Diseases 0.000 description 2
206010061928 radiculitis Diseases 0.000 description 2
230000002285 radioactive effect Effects 0.000 description 2
208000002574 reactive arthritis Diseases 0.000 description 2
108091008598 receptor tyrosine kinases Proteins 0.000 description 2
102000027426 receptor tyrosine kinases Human genes 0.000 description 2
NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
206010039073 rheumatoid arthritis Diseases 0.000 description 2
239000002336 ribonucleotide Substances 0.000 description 2
125000002652 ribonucleotide group Chemical group 0.000 description 2
102220240796 rs553605556 Human genes 0.000 description 2
210000003079 salivary gland Anatomy 0.000 description 2
201000000980 schizophrenia Diseases 0.000 description 2
230000028327 secretion Effects 0.000 description 2
208000007056 sickle cell anemia Diseases 0.000 description 2
108010000633 signal peptide receptor Proteins 0.000 description 2
230000011664 signaling Effects 0.000 description 2
239000010703 silicon Substances 0.000 description 2
229910052710 silicon Inorganic materials 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000007790 solid phase Substances 0.000 description 2
210000000952 spleen Anatomy 0.000 description 2
230000002269 spontaneous effect Effects 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
201000011549 stomach cancer Diseases 0.000 description 2
238000003860 storage Methods 0.000 description 2
201000000596 systemic lupus erythematosus Diseases 0.000 description 2
208000016505 systemic primary carnitine deficiency disease Diseases 0.000 description 2
208000001608 teratocarcinoma Diseases 0.000 description 2
210000001550 testis Anatomy 0.000 description 2
206010043554 thrombocytopenia Diseases 0.000 description 2
201000005060 thrombophlebitis Diseases 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
230000002103 transcriptional effect Effects 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
230000005945 translocation Effects 0.000 description 2
208000009999 tuberous sclerosis Diseases 0.000 description 2
210000004881 tumor cell Anatomy 0.000 description 2
229940035936 ubiquinone Drugs 0.000 description 2
241001515965 unidentified phage Species 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
229940035893 uracil Drugs 0.000 description 2
210000003932 urinary bladder Anatomy 0.000 description 2
201000010044 viral meningitis Diseases 0.000 description 2
208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 2
235000012431 wafers Nutrition 0.000 description 2
239000011534 wash buffer Substances 0.000 description 2
238000001086 yeast two-hybrid system Methods 0.000 description 2
KYRUKRFVOACELK-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(4-hydroxyphenyl)propanoate Chemical compound C1=CC(O)=CC=C1CCC(=O)ON1C(=O)CCC1=O KYRUKRFVOACELK-UHFFFAOYSA-N 0.000 description 1
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 1
UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 1
ZPZDIFSPRVHGIF-UHFFFAOYSA-N 3-aminopropylsilicon Chemical compound NCCC[Si] ZPZDIFSPRVHGIF-UHFFFAOYSA-N 0.000 description 1
208000009270 3-hydroxyacyl-CoA dehydrogenase deficiency Diseases 0.000 description 1
WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
101150094949 APRT gene Proteins 0.000 description 1
ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
102000004539 Acyl-CoA Oxidase Human genes 0.000 description 1
108020001558 Acyl-CoA oxidase Proteins 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
108010024223 Adenine phosphoribosyltransferase Proteins 0.000 description 1
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
108010025188 Alcohol oxidase Proteins 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
102100034452 Alternative prion protein Human genes 0.000 description 1
108090000672 Annexin A5 Proteins 0.000 description 1
102000004121 Annexin A5 Human genes 0.000 description 1
BNODVYXZAAXSHW-IUCAKERBSA-N Arg-His Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 BNODVYXZAAXSHW-IUCAKERBSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
206010003694 Atrophy Diseases 0.000 description 1
241001203868 Autographa californica Species 0.000 description 1
241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 1
108090001008 Avidin Proteins 0.000 description 1
WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
208000008720 Bone Marrow Neoplasms Diseases 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
240000007124 Brassica oleracea Species 0.000 description 1
238000011740 C57BL/6 mouse Methods 0.000 description 1
101100152433 Caenorhabditis elegans tat-1 gene Proteins 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
102100033040 Carbonic anhydrase 12 Human genes 0.000 description 1
206010007572 Cardiac hypertrophy Diseases 0.000 description 1
208000006029 Cardiomegaly Diseases 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
102100037182 Cation-independent mannose-6-phosphate receptor Human genes 0.000 description 1
101710145225 Cation-independent mannose-6-phosphate receptor Proteins 0.000 description 1
241000701489 Cauliflower mosaic virus Species 0.000 description 1
108010031896 Cell Cycle Proteins Proteins 0.000 description 1
102000005483 Cell Cycle Proteins Human genes 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
206010008190 Cerebrovascular accident Diseases 0.000 description 1
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
108010012236 Chemokines Proteins 0.000 description 1
102000019034 Chemokines Human genes 0.000 description 1
239000005496 Chlorsulfuron Substances 0.000 description 1
206010008631 Cholera Diseases 0.000 description 1
102000005853 Clathrin Human genes 0.000 description 1
108010019874 Clathrin Proteins 0.000 description 1
102100022641 Coagulation factor IX Human genes 0.000 description 1
102100033779 Collagen alpha-4(IV) chain Human genes 0.000 description 1
206010010099 Combined immunodeficiency Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
208000011990 Corticobasal Degeneration Diseases 0.000 description 1
241000186216 Corynebacterium Species 0.000 description 1
208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
241000192700 Cyanobacteria Species 0.000 description 1
UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
101150074155 DHFR gene Proteins 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
238000000018 DNA microarray Methods 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
101710088194 Dehydrogenase Proteins 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
206010061818 Disease progression Diseases 0.000 description 1
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
101100130497 Drosophila melanogaster Mical gene Proteins 0.000 description 1
102100021238 Dynamin-2 Human genes 0.000 description 1
102000001039 Dystrophin Human genes 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
102000001301 EGF receptor Human genes 0.000 description 1
108060006698 EGF receptor Proteins 0.000 description 1
UPEZCKBFRMILAV-JNEQICEOSA-N Ecdysone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@H]([C@@H](O)CCC(O)(C)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 UPEZCKBFRMILAV-JNEQICEOSA-N 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
101710091045 Envelope protein Proteins 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
108091029865 Exogenous DNA Proteins 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108010076282 Factor IX Proteins 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
108010087740 Fanconi Anemia Complementation Group A protein Proteins 0.000 description 1
102000009095 Fanconi Anemia Complementation Group A protein Human genes 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 description 1
244000228957 Ferula foetida Species 0.000 description 1
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
102000003983 Flavoproteins Human genes 0.000 description 1
108010057573 Flavoproteins Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 1
QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 1
CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
108090000079 Glucocorticoid Receptors Proteins 0.000 description 1
102100033417 Glucocorticoid receptor Human genes 0.000 description 1
102000053187 Glucuronidase Human genes 0.000 description 1
108010060309 Glucuronidase Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
230000025545 Golgi localization Effects 0.000 description 1
201000005569 Gout Diseases 0.000 description 1
102000016285 Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
108010067218 Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
108090001102 Hammerhead ribozyme Proteins 0.000 description 1
208000001204 Hashimoto Disease Diseases 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
208000031220 Hemophilia Diseases 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
241000711549 Hepacivirus C Species 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
WZOGEMJIZBNFBK-CIUDSAMLSA-N His-Asp-Asn Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O WZOGEMJIZBNFBK-CIUDSAMLSA-N 0.000 description 1
SDTPKSOWFXBACN-GUBZILKMSA-N His-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O SDTPKSOWFXBACN-GUBZILKMSA-N 0.000 description 1
YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
101000867855 Homo sapiens Carbonic anhydrase 12 Proteins 0.000 description 1
101000710870 Homo sapiens Collagen alpha-4(IV) chain Proteins 0.000 description 1
101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 1
101000835998 Homo sapiens SRA stem-loop-interacting RNA-binding protein, mitochondrial Proteins 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
101001042049 Human herpesvirus 1 (strain 17) Transcriptional regulator ICP22 Proteins 0.000 description 1
101000999690 Human herpesvirus 2 (strain HG52) E3 ubiquitin ligase ICP22 Proteins 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
102100030358 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Human genes 0.000 description 1
101710150008 Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial Proteins 0.000 description 1
208000000563 Hyperlipoproteinemia Type II Diseases 0.000 description 1
101150027427 ICP4 gene Proteins 0.000 description 1
USXAYNCLFSUSBA-MGHWNKPDSA-N Ile-Phe-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N USXAYNCLFSUSBA-MGHWNKPDSA-N 0.000 description 1
208000029462 Immunodeficiency disease Diseases 0.000 description 1
108020005350 Initiator Codon Proteins 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
108010025815 Kanamycin Kinase Proteins 0.000 description 1
208000001126 Keratosis Diseases 0.000 description 1
241000235058 Komagataella pastoris Species 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
108700005090 Lethal Genes Proteins 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
102100030659 Lipase member I Human genes 0.000 description 1
101710102461 Lipase member I Proteins 0.000 description 1
239000000232 Lipid Bilayer Substances 0.000 description 1
102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
108010062166 Lys-Asn-Asp Proteins 0.000 description 1
BYPMOIFBQPEWOH-CIUDSAMLSA-N Lys-Asn-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BYPMOIFBQPEWOH-CIUDSAMLSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
102000019218 Mannose-6-phosphate receptors Human genes 0.000 description 1
108050006616 Mannose-6-phosphate receptors Proteins 0.000 description 1
208000030162 Maple syrup disease Diseases 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
101100261636 Methanothermobacter marburgensis (strain ATCC BAA-927 / DSM 2133 / JCM 14651 / NBRC 100331 / OCM 82 / Marburg) trpB2 gene Proteins 0.000 description 1
208000019695 Migraine disease Diseases 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
108700005084 Multigene Family Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101100345589 Mus musculus Mical1 gene Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
206010028570 Myelopathy Diseases 0.000 description 1
229930193140 Neomycin Natural products 0.000 description 1
208000009869 Neu-Laxova syndrome Diseases 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108091093105 Nuclear DNA Proteins 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
238000009004 PCR Kit Methods 0.000 description 1
108091008606 PDGF receptors Proteins 0.000 description 1
108091007960 PI3Ks Proteins 0.000 description 1
241000526686 Paracoccidioides brasiliensis Species 0.000 description 1
206010033799 Paralysis Diseases 0.000 description 1
241000237988 Patellidae Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010067902 Peptide Library Proteins 0.000 description 1
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
101100124346 Photorhabdus laumondii subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01) hisCD gene Proteins 0.000 description 1
241000223960 Plasmodium falciparum Species 0.000 description 1
102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
102100030264 Pleckstrin Human genes 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
229920000037 Polyproline Polymers 0.000 description 1
241000881705 Porcine endogenous retrovirus Species 0.000 description 1
108091000054 Prion Proteins 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
102000003923 Protein Kinase C Human genes 0.000 description 1
108090000315 Protein Kinase C Proteins 0.000 description 1
101710188315 Protein X Proteins 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
101150060955 RAB11A gene Proteins 0.000 description 1
238000010802 RNA extraction kit Methods 0.000 description 1
239000013614 RNA sample Substances 0.000 description 1
102000042022 Rab family Human genes 0.000 description 1
108091079902 Rab family Proteins 0.000 description 1
102000011070 Rab3 Human genes 0.000 description 1
108050001276 Rab3 Proteins 0.000 description 1
102000028589 Rab4 Human genes 0.000 description 1
108050007312 Rab4 Proteins 0.000 description 1
101150118965 Rab4b gene Proteins 0.000 description 1
102100022873 Ras-related protein Rab-11A Human genes 0.000 description 1
108700005075 Regulator Genes Proteins 0.000 description 1
108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
108700008625 Reporter Genes Proteins 0.000 description 1
208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
102000006382 Ribonucleases Human genes 0.000 description 1
108010083644 Ribonucleases Proteins 0.000 description 1
108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
102000033686 SH3 domain binding proteins Human genes 0.000 description 1
108091009674 SH3 domain binding proteins Proteins 0.000 description 1
102100025491 SRA stem-loop-interacting RNA-binding protein, mitochondrial Human genes 0.000 description 1
108060006706 SRC Proteins 0.000 description 1
102000001332 SRC Human genes 0.000 description 1
206010039491 Sarcoma Diseases 0.000 description 1
241000242677 Schistosoma japonicum Species 0.000 description 1
241000235347 Schizosaccharomyces pombe Species 0.000 description 1
239000012506 Sephacryl® Substances 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
108700017825 Short chain Acyl CoA dehydrogenase deficiency Proteins 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
102100038624 Sorting nexin-5 Human genes 0.000 description 1
108050006125 Sorting nexin-5 Proteins 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
208000029033 Spinal Cord disease Diseases 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
241000282887 Suidae Species 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
206010043189 Telangiectasia Diseases 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
102000002932 Thiolase Human genes 0.000 description 1
108060008225 Thiolase Proteins 0.000 description 1
ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
SWSUXOKZKQRADK-FDARSICLSA-N Trp-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N SWSUXOKZKQRADK-FDARSICLSA-N 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
102000014384 Type C Phospholipases Human genes 0.000 description 1
108010079194 Type C Phospholipases Proteins 0.000 description 1
206010045261 Type IIa hyperlipidaemia Diseases 0.000 description 1
KWKJGBHDYJOVCR-SRVKXCTJSA-N Tyr-Ser-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O KWKJGBHDYJOVCR-SRVKXCTJSA-N 0.000 description 1
AFWXOGHZEKARFH-ACRUOGEOSA-N Tyr-Tyr-His Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CC=C(O)C=C1 AFWXOGHZEKARFH-ACRUOGEOSA-N 0.000 description 1
GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 1
LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
108020002494 acetyltransferase Proteins 0.000 description 1
102000005421 acetyltransferase Human genes 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
210000001789 adipocyte Anatomy 0.000 description 1
208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
238000011366 aggressive therapy Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
108010047495 alanylglycine Proteins 0.000 description 1
108010070944 alanylhistidine Proteins 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
102000009899 alpha Karyopherins Human genes 0.000 description 1
108010077099 alpha Karyopherins Proteins 0.000 description 1
UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
230000004075 alteration Effects 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
125000003277 amino group Chemical group 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
230000002788 anti-peptide Effects 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
210000001106 artificial yeast chromosome Anatomy 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
230000037444 atrophy Effects 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
OGBVRMYSNSKIEF-UHFFFAOYSA-L benzyl-dioxido-oxo-$l^{5}-phosphane Chemical compound [O-]P([O-])(=O)CC1=CC=CC=C1 OGBVRMYSNSKIEF-UHFFFAOYSA-L 0.000 description 1
DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
206010067728 beta-ketothiolase deficiency Diseases 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
238000010504 bond cleavage reaction Methods 0.000 description 1
201000006491 bone marrow cancer Diseases 0.000 description 1
206010006007 bone sarcoma Diseases 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
229950004398 broxuridine Drugs 0.000 description 1
244000309464 bull Species 0.000 description 1
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
229960003669 carbenicillin Drugs 0.000 description 1
230000021523 carboxylation Effects 0.000 description 1
238000006473 carboxylation reaction Methods 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
239000000969 carrier Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
102000028740 cation-dependent mannose-6-phosphate receptor Human genes 0.000 description 1
108010090156 cation-dependent mannose-6-phosphate receptor Proteins 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000024245 cell differentiation Effects 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
230000004656 cell transport Effects 0.000 description 1
210000004671 cell-free system Anatomy 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000030570 cellular localization Effects 0.000 description 1
230000007248 cellular mechanism Effects 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
210000001638 cerebellum Anatomy 0.000 description 1
230000003196 chaotropic effect Effects 0.000 description 1
VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical group COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
229930193282 clathrin Natural products 0.000 description 1
230000002566 clonic effect Effects 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
230000001427 coherent effect Effects 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
238000002648 combination therapy Methods 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000009137 competitive binding Effects 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
230000009918 complex formation Effects 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
208000014826 cranial nerve neuropathy Diseases 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
238000009402 cross-breeding Methods 0.000 description 1
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
210000005220 cytoplasmic tail Anatomy 0.000 description 1
230000003436 cytoskeletal effect Effects 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
230000007123 defense Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000003795 desorption Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
230000005750 disease progression Effects 0.000 description 1
230000009429 distress Effects 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
238000011143 downstream manufacturing Methods 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000007878 drug screening assay Methods 0.000 description 1
241001493065 dsRNA viruses Species 0.000 description 1
UPEZCKBFRMILAV-JMZLNJERSA-N ecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@H]([C@H](O)CCC(C)(C)O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 UPEZCKBFRMILAV-JMZLNJERSA-N 0.000 description 1
210000001705 ectoderm cell Anatomy 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
210000001900 endoderm Anatomy 0.000 description 1
210000003038 endothelium Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
239000013613 expression plasmid Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
229960004222 factor ix Drugs 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
201000001386 familial hypercholesterolemia Diseases 0.000 description 1
201000006061 fatal familial insomnia Diseases 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
235000019688 fish Nutrition 0.000 description 1
230000009969 flowable effect Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
238000002825 functional assay Methods 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000001476 gene delivery Methods 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
108010040856 glutamyl-cysteinyl-alanine Proteins 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
210000002288 golgi apparatus Anatomy 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
208000019622 heart disease Diseases 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
239000004009 herbicide Substances 0.000 description 1
238000012203 high throughput assay Methods 0.000 description 1
101150113423 hisD gene Proteins 0.000 description 1
125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
229940098197 human immunoglobulin g Drugs 0.000 description 1
235000020256 human milk Nutrition 0.000 description 1
210000004251 human milk Anatomy 0.000 description 1
150000002433 hydrophilic molecules Chemical class 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000003384 imaging method Methods 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
238000010324 immunological assay Methods 0.000 description 1
230000004957 immunoregulator effect Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
208000027866 inflammatory disease Diseases 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000007641 inkjet printing Methods 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
206010022437 insomnia Diseases 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
210000005061 intracellular organelle Anatomy 0.000 description 1
244000000056 intracellular parasite Species 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
238000007914 intraventricular administration Methods 0.000 description 1
238000007852 inverse PCR Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
XMBWDFGMSWQBCA-RNFDNDRNSA-M iodine-131(1-) Chemical compound [131I-] XMBWDFGMSWQBCA-RNFDNDRNSA-M 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
210000004153 islets of langerhan Anatomy 0.000 description 1
238000002955 isolation Methods 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
229940043355 kinase inhibitor Drugs 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
238000011068 loading method Methods 0.000 description 1
230000004807 localization Effects 0.000 description 1
230000007774 longterm Effects 0.000 description 1
238000005461 lubrication Methods 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
230000002132 lysosomal effect Effects 0.000 description 1
230000002101 lytic effect Effects 0.000 description 1
101710130522 mRNA export factor Proteins 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
208000024393 maple syrup urine disease Diseases 0.000 description 1
238000002483 medication Methods 0.000 description 1
230000007721 medicinal effect Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
108020004084 membrane receptors Proteins 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
210000003716 mesoderm Anatomy 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
238000012775 microarray technology Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
229960003248 mifepristone Drugs 0.000 description 1
206010027599 migraine Diseases 0.000 description 1
239000011707 mineral Substances 0.000 description 1
239000003607 modifier Substances 0.000 description 1
238000001823 molecular biology technique Methods 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
238000002887 multiple sequence alignment Methods 0.000 description 1
230000003387 muscular Effects 0.000 description 1
201000000585 muscular atrophy Diseases 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
230000002151 myoclonic effect Effects 0.000 description 1
102000006392 myotrophin Human genes 0.000 description 1
108010058605 myotrophin Proteins 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
239000006225 natural substrate Substances 0.000 description 1
230000010807 negative regulation of binding Effects 0.000 description 1
229960004927 neomycin Drugs 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
230000002232 neuromuscular Effects 0.000 description 1
231100000956 nontoxicity Toxicity 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
239000003921 oil Substances 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
208000021090 palsy Diseases 0.000 description 1
230000005298 paramagnetic effect Effects 0.000 description 1
210000002990 parathyroid gland Anatomy 0.000 description 1
239000004031 partial agonist Substances 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
108010054300 peroxisomal acyl-CoA oxidase Proteins 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
239000012071 phase Substances 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
BQVCCPGCDUSGOE-UHFFFAOYSA-N phenylarsine oxide Chemical compound O=[As]C1=CC=CC=C1 BQVCCPGCDUSGOE-UHFFFAOYSA-N 0.000 description 1
108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
239000003757 phosphotransferase inhibitor Substances 0.000 description 1
DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
238000000206 photolithography Methods 0.000 description 1
108010026735 platelet protein P47 Proteins 0.000 description 1
229920001983 poloxamer Polymers 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
108010026466 polyproline Proteins 0.000 description 1
230000004481 post-translational protein modification Effects 0.000 description 1
229940124606 potential therapeutic agent Drugs 0.000 description 1
239000000843 powder Substances 0.000 description 1
235000008476 powdered milk Nutrition 0.000 description 1
238000002953 preparative HPLC Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000037452 priming Effects 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
230000001915 proofreading effect Effects 0.000 description 1
230000001902 propagating effect Effects 0.000 description 1
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000004445 quantitative analysis Methods 0.000 description 1
230000006340 racemization Effects 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
210000003370 receptor cell Anatomy 0.000 description 1
238000004064 recycling Methods 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
230000027756 respiratory electron transport chain Effects 0.000 description 1
230000029058 respiratory gaseous exchange Effects 0.000 description 1
210000001995 reticulocyte Anatomy 0.000 description 1
210000003660 reticulum Anatomy 0.000 description 1
230000002207 retinal effect Effects 0.000 description 1
201000002220 retinal hemangioblastoma Diseases 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
239000003161 ribonuclease inhibitor Substances 0.000 description 1
210000003705 ribosome Anatomy 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000013391 scatchard analysis Methods 0.000 description 1
238000005204 segregation Methods 0.000 description 1
238000010187 selection method Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
230000000405 serological effect Effects 0.000 description 1
208000001392 short chain acyl-CoA dehydrogenase deficiency Diseases 0.000 description 1
230000019491 signal transduction Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000010473 stable expression Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000013179 statistical model Methods 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
230000007019 strand scission Effects 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
230000005657 synaptic vesicle exocytosis Effects 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
208000009056 telangiectasis Diseases 0.000 description 1
238000010998 test method Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
231100001274 therapeutic index Toxicity 0.000 description 1
238000005382 thermal cycling Methods 0.000 description 1
229940094937 thioredoxin Drugs 0.000 description 1
210000001685 thyroid gland Anatomy 0.000 description 1
238000012090 tissue culture technique Methods 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
210000003412 trans-golgi network Anatomy 0.000 description 1
108091008023 transcriptional regulators Proteins 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000007723 transport mechanism Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
230000010415 tropism Effects 0.000 description 1
101150081616 trpB gene Proteins 0.000 description 1
101150111232 trpB-1 gene Proteins 0.000 description 1
238000010396 two-hybrid screening Methods 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
238000004506 ultrasonic cleaning Methods 0.000 description 1
230000009452 underexpressoin Effects 0.000 description 1
DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
229940045145 uridine Drugs 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
210000003934 vacuole Anatomy 0.000 description 1
239000004474 valine Substances 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
QAOHCFGKCWTBGC-UHFFFAOYSA-N wybutosine Natural products C1=NC=2C(=O)N3C(CCC(NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1C1OC(CO)C(O)C1O QAOHCFGKCWTBGC-UHFFFAOYSA-N 0.000 description 1
QAOHCFGKCWTBGC-QHOAOGIMSA-N wybutosine Chemical compound C1=NC=2C(=O)N3C(CC[C@H](NC(=O)OC)C(=O)OC)=C(C)N=C3N(C)C=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O QAOHCFGKCWTBGC-QHOAOGIMSA-N 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1